Telaprevir therapy, renal impairment, and their effects on the pharmacokinetics of tenofovir in HIV/hepatitis C virus coinfected patients

被引:5
|
作者
Gervasoni, Cristina [1 ]
Milazzo, Laura [1 ]
Pezzani, Diletta [1 ]
Fucile, Serena [2 ]
Cattaneo, Dario [2 ]
机构
[1] Luigi Sacco Univ Hosp, Div Infect Dis 3, I-20157 Milan, Italy
[2] Luigi Sacco Univ Hosp, Clin Pharmacol Unit, I-20157 Milan, Italy
关键词
KIDNEY; ASSOCIATION; EXPOSURE;
D O I
10.1097/QAD.0000000000000088
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:285 / 287
页数:3
相关论文
共 50 条
  • [1] Telaprevir in patients coinfected with hepatitis C virus and HIV
    Gallego Galisteo, M.
    Tellez Perez, F.
    Infante Chacon, N.
    Roldan Morales, J. C.
    Perez Perez, M.
    Avila Alvarez, J. R.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 972 - 973
  • [2] Telaprevir-based therapy in patients coinfected with chronic hepatitis C virus infection and HIV: INSIGHT study
    Luisa Montes, Maria
    Nelson, Mark
    Girard, Pierre-Marie
    Sasadeusz, Joe
    Horban, Andrzej
    Grinsztejn, Beatriz
    Zakharova, Natalia
    Rivero, Antonio
    Durant, Jacques
    Ortega-Gonzalez, Enrique
    Lathouwers, Erkki
    Janssen, Katrien
    Ouwerkerk-Mahadevan, Sivi
    Witek, James
    Gonzalez-Garcia, Juan
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (01) : 244 - 250
  • [3] Etravirine-based antiretroviral therapy in HIV/hepatitis C virus coinfected advanced fibrosis patients receiving triple therapy against hepatitis C virus with telaprevir
    Montes Ramirez, Maria Luisa
    Zamora Vargas, Francisco X.
    Gonzalez-Garcia, Juan
    Quereda, Carmen
    Jesus Perez-Elias, Maria
    Mena de Cea, Alvaro
    Barros, Carlos
    Condes, Emilia
    Sanz Moreno, Jose
    Santos, Ignacio
    Torralba, Miguel
    Aldamiz-Echevarria, Teresa
    Moreno, Ana
    AIDS, 2014, 28 (16) : 2487 - 2489
  • [4] Adherence to Hepatitis C Virus Therapy in HIV/Hepatitis C-Coinfected Patients
    Vincent Lo Re
    Valerie Teal
    A. Russell Localio
    Valerianna K. Amorosa
    David E. Kaplan
    Robert Gross
    AIDS and Behavior, 2013, 17 : 94 - 103
  • [5] Pharmacokinetics of lopinavir/ritonavir in HIV/hepatitis C virus-coinfected subjects with hepatic impairment
    Peng, JZ
    Pulido, F
    Causemaker, SJK
    Li, JL
    Lorenzo, A
    Cepeda, C
    Cabanillas, JAG
    DaSilva, B
    Brun, SC
    Arribas, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (03): : 265 - 274
  • [6] Adherence to Hepatitis C Virus Therapy in HIV/Hepatitis C-Coinfected Patients
    Lo Re, Vincent, III
    Teal, Valerie
    Localio, A. Russell
    Amorosa, Valerianna K.
    Kaplan, David E.
    Gross, Robert
    AIDS AND BEHAVIOR, 2013, 17 (01) : 94 - 103
  • [7] Treatment outcomes with telaprevir-based therapy for HIV/hepatitis C coinfected patients are comparable with hepatitis C monoinfected patients
    O'Neil, Conar R.
    Pang, Jack X. Q.
    Lee, Samuel S.
    Swain, Mark G.
    Burak, Kelly W.
    Klein, Patricia
    Myers, Robert P.
    Kapler, Jeff
    Gill, Michael J.
    Labrie, Martin
    Coffin, Carla S.
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2015, 26 (06): : 293 - 296
  • [8] Telaprevir decreases estimated glomerular filtration rate in HIV-hepatitis C virus coinfected patients
    Van den Eynde, Eva
    Curto, Jordi
    Ferrer, Elena
    Imaz, Arkaitz
    Saumoy, Maria
    Di Yacovo, Silvana
    Vila, Antonia
    Podzamczer, Daniel
    AIDS, 2015, 29 (08) : 977 - 979
  • [9] Boceprevir and telaprevir-based regimens for the treatment of hepatitis C virus in HIV/HCV coinfected patients
    Beste, Lauren A.
    Green, Pamela K.
    Ioannou, George N.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (02) : 123 - 129
  • [10] Serious neuropsychiatric adverse effects in a hepatitis C virus/hepatitis B virus/HIV-coinfected patient receiving bosentan and telaprevir
    Le, Minh P.
    Gervais, Anne
    Le Beller, Christine
    Long, Kivan
    Larrouy, Lucile
    Papy, Emmanuelle
    Mal, Herve
    Descamps, Diane
    Peytavin, Gilles
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (05) : 1208 - 1209